GAMCO INVESTORS, INC. ET AL
Q4 2020 13F-HR Holdings
Net value change ($000)
+1,681,626
(18.7%)
New positions
85
Sold out positions
70
Turnover %
6.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| NAV | 134,672 | NEW |
| HRI | 85,108 | 63.2% |
| CNH INDL N V | 49,354 | 62.7% |
| AEROJET ROCKETDYNE HOLDINGS, INC. | 46,880 | 38.1% |
| RHP | 43,496 | 72.3% |
| CXT | 41,223 | 52.1% |
| SONY | 40,587 | 24.1% |
| KAMAN Corp | 35,095 | 41.6% |
| GATX | 34,981 | 28.8% |
| DIS | 31,967 | 44.9% |
Top Reduces (Value $000, Stocks/ETFs)
| NAVISTAR INTERNATIONAL CORP | -151,899 | -100.0% |
| QUIDEL CORP /DE/ | -27,276 | -42.2% |
| GRIZZLY MERGER SUB 1, LLC | -22,978 | -100.0% |
| TERMINIX GLOBAL HOLDINGS INC | -22,682 | -100.0% |
| MOMENTA PHARMACEUTICALS INC | -17,458 | -100.0% |
| AARON'S INC | -14,218 | -100.0% |
| LPX | -8,778 | -57.9% |
| ROSETTA STONE INC | -8,712 | -100.0% |
| IMMUNOMEDICS INC | -8,082 | -100.0% |
| Aimmune Therapeutics, Inc. | -7,378 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|